FATF urges India to reduce pending laundering cases | India News – Times of India

FATF urges India to reduce pending laundering cases | India News – Times of India

NEW DELHI: While lauding India on most counts, Financial Action Task Force (FATF), the global money laundering and terror financing watchdog, has called for efforts to reduce pending money laundering cases and recommended “major changes” to address prosecution in terror financing cases.FATF’s Mutual Evaluation Report on India, released on Thursday, noted that the main sources…

Read More
‘It’s discouraging when …’: Ajit Pawar laments lack of credit for Baramati development efforts | India News – Times of India

‘It’s discouraging when …’: Ajit Pawar laments lack of credit for Baramati development efforts | India News – Times of India

NEW DELHI: Maharashtra deputy chief minister Ajit Pawar on Tuesday voiced his disappointment over the lack of appreciation for his development efforts in Baramati. Despite securing substantial funds for Baramati, Pawar believes that his efforts have been taken for granted. Reflecting on his loss in the Lok Sabha elections, Pawar accepted responsibility but pointed to…

Read More
Two women naval officers set for round-the-world sailing expedition | India News – Times of India

Two women naval officers set for round-the-world sailing expedition | India News – Times of India

NEW DELHI: Two women naval officers, Lieutenant Commanders Roopa A and Dilna K, are now all set to embark on a sailing expedition to circumnavigate the globe after three years of arduous training.The two young officers will soon begin their expedition called ‘Navika Sagar Parikrama-II‘ onboard the indigenously built 56-foot sailing vessel INSV Tarini.”It will…

Read More
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday.  Patients with the condition, called cancer cachexia, who took Pfizer’s treatment saw improvements in body weight, muscle mass, quality of life and physical function, according to…

Read More